| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/14/1992 | WO1992007937A1 Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides |
| 05/14/1992 | WO1992007936A1 Cloning and expression of biologically active alpha-n-acetylgalactosaminidase |
| 05/14/1992 | WO1992007875A1 Cytolytic factor associated with effector cell plasma membranes |
| 05/14/1992 | WO1992007874A1 Pharmaceutically active proteins comprising an active protein and an integrinaffinity sequence |
| 05/14/1992 | WO1992007872A1 Tenascin related peptides |
| 05/14/1992 | WO1992007871A1 Peptide-based inhibitors of hiv replication |
| 05/14/1992 | WO1992007869A1 Inhibitors and substrates of thrombin |
| 05/14/1992 | WO1992007865A1 Human gene encoding adrenodoxin reductase |
| 05/14/1992 | WO1992007587A1 Methods and compositions for amelioration of skin wrinkles |
| 05/14/1992 | WO1992007584A1 Pharmaceutical preparation for the treatment of prolonged coagulation time |
| 05/14/1992 | WO1992007583A1 ANTI-UBIQUITIN IgG IN THE TREATMENT OF SYSTEMIC AMYLOIDOSIS |
| 05/14/1992 | WO1992007578A1 Use of protective agents against reactive oxygen species |
| 05/14/1992 | WO1992007577A1 Antitumoral composition based on polypeptides having human interleukin 2 activity |
| 05/14/1992 | WO1992007574A1 Glycoproteins associated with membrane-bound immunoglobulins as antibody targets on b cells |
| 05/14/1992 | WO1992007573A1 Genetic modification of endothelial cells |
| 05/14/1992 | WO1992007568A1 η-TURN PEPTIDOMIMETICS AS FIBRINOGEN ANTAGONISTS |
| 05/14/1992 | WO1992007566A2 Antifungal activity of and prevention of drug induced nephrotoxicity by methylxanthine analogues |
| 05/14/1992 | WO1992007556A1 Polyvinyl alcohol coated pellet of growth hormone |
| 05/14/1992 | WO1992004014A3 Regulation of neoplastic cell proliferation via a novel 5ht1a receptor |
| 05/14/1992 | WO1992002621A3 Allergens of alder pollen and applications thereof |
| 05/14/1992 | WO1992001718A3 Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/14/1992 | WO1991018984A3 New antifungal preparations, process for making such preparations, process for obtaining plants with decreased susceptibility to fungi |
| 05/14/1992 | DE4035877A1 O-glycosylated alpha interferon |
| 05/14/1992 | CA2095356A1 Pharmaceutical preparation for the treatment of prolonged coagulation time |
| 05/14/1992 | CA2095330A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | CA2095256A1 Retroviral vectors useful for gene therapy |
| 05/14/1992 | CA2094922A1 Cloning and expression of biologically active alpha-n-acetylgalactosaminidase |
| 05/14/1992 | CA2094378A1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 05/14/1992 | CA2092075A1 Peptide-based inhibitors of hiv replication |
| 05/14/1992 | CA2071973A1 Antitumoral composition based on polypeptides having human interleukin 2 activity |
| 05/14/1992 | CA2055425A1 Polypeptide, dna fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same |
| 05/14/1992 | CA2055146A1 Method for blocking platelet adhesion to collagen |
| 05/14/1992 | CA2055122A1 Methods for stimulating ldl uptake and ldl receptor expression |
| 05/13/1992 | EP0485173A2 Esters and amides of substituted fused ring phenyl acetic acids |
| 05/13/1992 | EP0485158A2 Esters and amides of substituted phenyl acetic acids |
| 05/13/1992 | EP0485143A1 Liposomal compositions and processes for their production |
| 05/13/1992 | EP0484719A2 Tachykinin antagonist |
| 05/13/1992 | EP0484477A1 Maturation of hemopoietic cells |
| 05/13/1992 | EP0484452A1 Fibulin |
| 05/13/1992 | EP0484416A1 Regulation of nerve growth factor synthesis in the central nervous system |
| 05/13/1992 | EP0484380A1 Uses of interleukin-4 and method for purifying it |
| 05/13/1992 | EP0195015B1 Pharmaceutical composition for combination therapy of hormone dependent cancers |
| 05/13/1992 | CN1060948A Nutritional composition and process for its production |
| 05/12/1992 | US5112953 Radiolabeled proteins for diagnostic or therapeutic use |
| 05/12/1992 | US5112950 Factor viii analog, preparation process, and pharmaceutical composition containing it |
| 05/12/1992 | US5112949 Method of and apparatus for separating proteins |
| 05/12/1992 | US5112948 Methods and compositions for inducing monocyte cytotoxicity |
| 05/12/1992 | US5112947 Oligopeptides, nootropic agents |
| 05/12/1992 | US5112946 Polypeptides and proteins with mutant segments for treatment of cardiovascular disorders and antitumor agents |
| 05/12/1992 | US5112945 Preparation of islet amyloid polypeptides (iapp) and antibodies to iapp |
| 05/12/1992 | US5112944 Antitumor agents |
| 05/12/1992 | US5112811 Sdk peptides and therapeutic compositions containing them |
| 05/12/1992 | US5112810 Nonapeptides for thymic factor and multiple sclerosis treatment |
| 05/12/1992 | US5112809 CRF analogs |
| 05/12/1992 | US5112808 Alkylated hormone-releasing peptides and method of treatig mammals therewith |
| 05/12/1992 | US5112806 Antibiotic, mersacidin, a process for the preparation thereof and the use thereof as a pharmaceutical |
| 05/12/1992 | US5112805 Pharmaceutical preparation for promoting epithelial healing and prevention of epithelial destruction |
| 05/12/1992 | US5112755 DNA coding sequence expressed in Escherichia, genetic engineering |
| 05/12/1992 | US5112754 Tissue plasminogen-activating factor and nonoclonal antibody |
| 05/12/1992 | US5112744 Plasmids for the production of human Cu-Zn superoxide dismutase, bacterial hosts containing the plasmids and methods for production and recovery of such superoxide dismutase |
| 05/12/1992 | US5112615 Soluble hirudin conjugates |
| 05/12/1992 | US5112611 Pharmaceutical compositions for aiding human digestion |
| 05/12/1992 | US5112609 Improved solubility of tissue plasminogen activator |
| 05/12/1992 | US5112608 Use of protease nexin-I to mediate wound healing |
| 05/12/1992 | US5112605 Temporal gamma-interferon administration for allergies |
| 05/12/1992 | US5112596 A composition of a neuropharmaceutical or diagnostic agent, a bradykinin agonist to increase blood brain barrier permeability |
| 05/12/1992 | CA1300807C Heterocyclic derivatives |
| 05/12/1992 | CA1300536C Process for antifungal fermentation product and culture |
| 05/12/1992 | CA1300510C Stabilized composition containing angiotensin converting enzyme |
| 05/12/1992 | CA1300502C Antipyretic and anti-inflammatory peptides |
| 05/12/1992 | CA1300501C Ovulation treatment |
| 05/10/1992 | WO1992008804A1 Erythrocytes and thrombo-erythrocytes as target specific agents |
| 05/10/1992 | WO1992008801A1 Bridging antibody fusion constructs |
| 05/10/1992 | WO1992008793A1 Chinese hamster ovary cell retrovirus-like c particles |
| 05/10/1992 | WO1992008495A1 Cytokine immunoconjugates |
| 05/10/1992 | CA2095925A1 Erythrocytes and thrombo-erythrocytes as target specific abents |
| 05/10/1992 | CA2095842A1 Bridging antibody fusion constructs |
| 05/10/1992 | CA2095635A1 Chinese hamster ovary cell retrovirus-like c particles |
| 05/09/1992 | WO1992008736A1 Hirudine mutant, production thereof, anticoagulant, secretory vector, microorganism transformed by said vector, and production of product from said microorganism |
| 05/09/1992 | CA2255396A1 Hirudin analog, method of manufacturing thereof and anti-coagulant composition, and secretion vector, transformed microorganisms containing said vector and manufacturing method ofproducts which is produced from said microorganism |
| 05/08/1992 | WO1992008456A2 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 05/08/1992 | CA2095732A1 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 05/07/1992 | WO1992007579A1 Soluble mannose receptor peptides |
| 05/07/1992 | DE4034707A1 New hydroxyethyl-amine and norstatin-type pseudo:peptide(s) |
| 05/07/1992 | CA2095729A1 Soluble mannose receptor peptides |
| 05/06/1992 | WO1992007580A1 Therapeutic uses of melanin |
| 05/06/1992 | EP0484281A2 Cyclosporins |
| 05/06/1992 | EP0484148A1 A method for producing a new medicine for both treating and preventing peptic ulcer diseases and gastritis and thus formulated medicines |
| 05/06/1992 | EP0484017A2 Endothelin precursors, genes and receptors |
| 05/06/1992 | EP0483961A1 Specific binding agents |
| 05/06/1992 | EP0483765A2 Method for activating lymphocyte |
| 05/06/1992 | EP0483643A2 Use of macrophage colony-stimulating factor in the treatment of cachexia |
| 05/06/1992 | EP0483465A1 Long chain di(acyloxy)dialkylsilanes, di(acyloxy)diarylsilanes, di(acyloxy)dialkoxysilanes, and tetra(acyloxy)silanes, process for their preparation, their use for the preparation of vesicles, so produced vesicles and their use as vehicles for drugs |
| 05/06/1992 | EP0483351A1 Soluble single chain t cell receptors |
| 05/06/1992 | EP0483304A1 Method of inactivation of viral and bacterial blood contaminants |
| 05/06/1992 | EP0483281A1 Recombinant human thyroid peroxidase |
| 05/06/1992 | EP0483271A1 Peptides containing diamino-glycols as transition-state mimics. |
| 05/06/1992 | EP0483261A1 Hirudin peptide derivatives |
| 05/06/1992 | EP0483249A1 Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators |
| 05/06/1992 | EP0483247A1 Recombinantly produced human membrane cofactor protein (mcp) |